The Fred Hutchinson Cancer Research Center and the University of Washington Medicine in Seattle are pleased to announce the arrival soon of Dr. Eric Holland, a world-class brain cancer research scientist and neurosurgeon, who will head up the Human Biology Division at Hutch as well as the Alvord Brain Tumor Center at UW. The eminent MD/PhD is being lured away from Manhattan's Memorial Sloan-Kettering Cancer Center, where he directs the MSKCC brain tumor center and has his lab within the Cancer Biology and Genetics Program, where his team studies the molecular mechanisms underlying the development of central nervous system tumors. In addition to being the recipient of many prestigious awards over years, Holland brings with him over $3M a year in NIH/NCI funding. It's unclear how many of his 13 lab members will follow him across the country to take on new challenges at Hutch and UW.
[Photo courtesy of Memorial Sloan-Kettering Cancer Center]
Of his move from the East to the West Coast, Dr. Holland had this to say in a recent press release:
"I am thrilled at the prospect of working with the world’s leading experts in genome sciences, computational biology and those involved in the development of novel platforms for delivering innovative therapies to cancer patients. The highly collaborative, multidisciplinary nature of cancer research at Fred Hutch and UW Medicine provides a solid foundation to build on.”
In addition to setting up his new research lab at Fred Hutch, one of Dr. Holland's other pressing tasks when he arrives in Seattle will be to recruit 6 additional lab research scientists to UW Medicine's Alvord Brain Tumor Center. The interdisciplinary center that Holland will develop is the product of 6 endowed chairs made possible by the family of the late Dr. Buster Alvord, a UW professor of pathology and neurosurgeon for over 40 years. In his time at MSKCC, Holland is credited with establishing the very successful Brain Tumor Center uniting brain cancer research and clinical care at MSKCC. UW looks forward to a seeing a similarly strong brain tumor translational research program develop in Seattle's life science community under Holland's leadership.
[Seattle skyline at sunset, courtesy of starvingphotographer.com and the UW Dept. of Radiology]
NIH fiscal year 2013 funding for all programs at Fred Hutch already amount to $32,684,011 (76 awards so far); 2012 fiscal year funding came to a total $250,289,941 for 254 awards. 2012 NIH awards for the University of Washington Seattle totalled $458,666,336; 2013 funding is at $101,074,273 for the partial year. Both research institutions also have considerable state, philanthropic, and industry support.
Meet with researchers at Fred Hutchinson Cancer Research Center when Biotechnology Calendar Inc. holds its 8th Annual FHCRC BioResearch Product Faire™ event at the Center in Seattle October 23, 2013. For information on exhibiting and a free funding report, click the button:
To register to attend the upcoming event, click here.
We will be at the University of Washington in Seattle the following day, October 24, 2013, to hold our 23rd annual UW BioResearch Product Faire™ FrontLine™ event. For information:
Biotechnology Calendar, Inc. is a full-service event marketing and planning company producing on-campus life science research tradeshows nationwide for over 20 years. We plan and promote each event to bring the best products and services to the best research campuses across the country. Life science researchers, purchasing agents, and lab managers are actively invited to attend to see the latest products and equipment and discuss their laboratory tool and service needs. See our nationwide show schedule for 2013.